Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Байесов модел на пропорционалните опасности на Кокс× | Анализ на преживяемостта× | |
|---|---|---|
| Област≠ | Епидемиология | Статистика за изследвания |
| Семейство | Process / pipeline | Process / pipeline |
| Година на възникване≠ | 1972 (Cox); Bayesian formulation developed through the 1990s | 1958 |
| Създател≠ | D. R. Cox (frequentist CPH, 1972); Bayesian extensions by Joseph Ibrahim, Ming-Hui Chen, Debajyoti Sinha (1990s–2001) | Edward L. Kaplan and Paul Meier |
| Тип≠ | Bayesian semiparametric survival regression | Method |
| Основополагащ източник≠ | Ibrahim, J. G., Chen, M.-H., & Sinha, D. (2001). Bayesian Survival Analysis. Springer. ISBN: 978-0387952772 | Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53(282), 457–481. DOI ↗ |
| Други названия≠ | Bayesian CPH, Bayesian survival regression, Bayesian semiparametric hazard model, Bayesian partial likelihood survival model | Kaplan-Meier analysis, Cox regression, TTE analysis |
| Свързани≠ | 4 | 3 |
| Резюме≠ | The Bayesian Cox proportional hazards model combines Cox's classical semiparametric survival regression with Bayesian inference, replacing point estimates and p-values with full posterior distributions over regression coefficients. It handles right-censored time-to-event outcomes, quantifies uncertainty about hazard ratios in probabilistic terms, and allows the incorporation of prior clinical or historical knowledge directly into the analysis. | Survival analysis is a collection of statistical methods for modeling time from a defined starting point until an event of interest occurs (disease, recovery, death, equipment failure). Kaplan and Meier's nonparametric estimator (1958) and David Cox's proportional hazards model (1972) jointly enabled analysis of censored data—individuals whose event times are unknown because they left the study or were still event-free at follow-up. Indispensable in oncology, cardiology, infectious disease research, engineering reliability, and any field where time-to-event matters. |
| ScholarGateНабор от данни ↗ |
|
|